Skip to main content
Log in

Genetic screening to identify the gene carrier in Italian and German kindreds affected by multiple endocrine neoplasia type 1 (MEN 1) syndrome

  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Multiple endocrine neoplasia type 1 (MEN 1) is an autosomal dominantly inherited disorder characterized by parathyroid hyperplasia, anterior pituitary adenomas and neoplasms of the endocrine cells of the gastroenteric tract. It has been established that also other tissues exhibit excessive proliferation associated to the MEN 1 syndrome: carcinoids (bronchial and intestinal), lipomas (visceral and cutaneous), thyroid adenomas and goiter, and adrenal gland cortex adenomas. The men1 gene has been mapped by genetic studies to the long arm of human chromosome 11, region q12–13. Genetic analysis of families and tumoral deletion mapping made possible to narrow the men1 region to a 5 cM interval on chromosome 11q12–13. Thirteen marker complexes (17 DNA probes) were found to be linked to the men 1 gene and they span a 14% meiotic recombination with the men 1 locus in the middle. We report a genetic study on 103 subjects from 7 collected MEN 1-kindreds, six Italian and one German, including 30 affected individuals. By linkage analysis to 9 DNA markers (10 DNA probes) of the chromosome region where the men 1 gene maps (11q12–13), we identified 10 mutant gene carriers. The predicted MEN 1 diagnosis was clinically confirmed for 2 of these identified carriers. A predictive accuracy of this genetic test can reach up to 99.5% when it is possible to exclude meiotic crossing-over between the analyzed DNA markers and the disease locus.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Lips C.J.M., Vasen H.F.A., Lamers C.B.H.W. Multiple Endocrine Neoplasia. CRC Crit. Rev. Oncol. Hematol. 2: 117, 1984.

    Article  CAS  Google Scholar 

  2. Duh Q.Y., Hybarger C.P., Geist R., Gamsu G.. Goodman P.C., Gooding G.A.W., Clark O.H. Carcinoid associated with multiple endocrine neoplasia syndromes. Am. J. Surg. 154: 142,1987.

    Article  PubMed  CAS  Google Scholar 

  3. Lamers C.B., Froeling P.G. Clinical significance of hyperparathyroidism in familial multiple endocrine adenomatosis type I (MEA). Am. J. Med. 66: 422,1979.

    Article  PubMed  CAS  Google Scholar 

  4. Marx S.J., Vinik A.I., Santen R.J. Floyd J. C., Mills J.L., Green III J. Multiple endocrine neoplasia type I: assesment of laboratory tests to screen for the gene in a large kindred Medicine 65: 226, 1986.

    Article  PubMed  CAS  Google Scholar 

  5. Oberg F., Walinder O., Bostrom H., Lundqvist G., Wide L. Peptide hormone markers in screening for endocrine tumors in multiple endocrine adenomatosis type 1. Am. J. Med. 73: 619, 1982.

    Article  PubMed  CAS  Google Scholar 

  6. Eberle F., Grun R. Multiple endocrine neoplasia type I (MEN 1). Ergeb Inn. Med. Kinderheilkd 46: 76, 1981.

    PubMed  CAS  Google Scholar 

  7. Croisier J.C., Lehy T., Zeitoun P. A2 cell pancreatic microadenomas in a case of multiple endocrine adenomatosis. Cancer 28: 707, 1971.

    Article  PubMed  CAS  Google Scholar 

  8. Peaurifory J.T., Gomez L.G., Thompson J.S. Separate pancreatic gastrin cell and beta-cell adenomas: report of a patient with multiple endocrine adenomatosis type 1. Archiv. Surg. 114: 956, 1979.

    Article  Google Scholar 

  9. Tiengo A., Fedek D., Marchiori E., Nosadini R., Muggeo M. Suppression and stimulation mechanism controlling glucagon secretion in a case of islet cell tumour producing glucagon, insulin and gastrin. Diabetes 25: 408, 1986.

    Article  Google Scholar 

  10. Long R.G., Bryant M.G., Mitchell S.J., Adrian T.E., Polak J.M., Bloom S.R. Clinopathological study of pancreatic and ganglioneuroblastoma tumour secreting vasoactive intestinal polypeptide (VIPoma). Lancet 2: 764, 1979.

    Article  PubMed  CAS  Google Scholar 

  11. Yamaguchi K., Kameya T., Abe K. Multiple endocrine neoplasia type Clin. I. Endocrinol. Metab. 9: 261,1980.

    CAS  Google Scholar 

  12. Kloppel G., Willener S., Stamm B., Hacki W. H., Heitz P.U. Pancreatic lesions and hormonal profile of pancreatic tumors in multiple endocrine neoplasia type 1. An immunocytochemical study of nine patients. Cancer 57: 1824,1986.

    Article  PubMed  CAS  Google Scholar 

  13. Majewski J.T., Wilson S.D. The MEA-syndrome: An all or none phenomenon? Surgery 86:475,1979.

    PubMed  CAS  Google Scholar 

  14. O’Neal L.W., Kipnis D.M., Luse S.A., Lacy P.E., Jarret L. Secretion of various endocrine substances by ACTH-secreting tumors-gastrin, melanotropin, norepinephrine, serotonin, parathormone, vasopressin, glucagon. Cancer 21: 1219, 1968.

    Article  Google Scholar 

  15. Marx S.J., Spiegel A.M., Brown E.M., Aurbach G.D. Family studies in patients with primary parathyroid hyperplasia. Am. J. Med. 62: 698,1977.

    Article  PubMed  CAS  Google Scholar 

  16. Hershon K.S., Kelly W.A., Shaw C.M., Schwartz R., Bierman E.L. Prolactinima as part of the multiple endocrine neoplastic syndrome. Am. J. Med. 74: 713,1983.

    Article  PubMed  CAS  Google Scholar 

  17. Bear J.C., Briones-Urbina R., Fahey J.F., Farid N.R. Variant multiple neoplasia type I (MEN I-Buri): further studies and non-linkage to HLA. Hum. Hered. 35:15,1985.

    Article  PubMed  CAS  Google Scholar 

  18. Farid N.R., Buehler S., Rüssel N.A., Maroun F.B., Allerdice P., Smyth H.S. Prolactinoma in familial multiple endocrine neoplasia type I. Am. J. Med. 69: 874,1980.

    Article  PubMed  CAS  Google Scholar 

  19. Skogseid B., Eriksson B., Lundkvist G., Lorelius L., Rastad J., Wide L., Akerstrom G., Oberg K.J. Multiple endocrine neoplasia type I-A ten ytear prospective screening study in four kindreds. J. Clin. Endocrinol. Metab. 73: 281,1991.

    Article  PubMed  CAS  Google Scholar 

  20. Brandi M.L., Marx S.J., Aurbach J.D., Fitzpatrick L.A. Familial multiple endocrine neoplasia type I: a new look at pathophysiology. Endocr. Rev. 8: 391,1987.

    Article  PubMed  CAS  Google Scholar 

  21. Brandi M.L., Weber G., Svensson A., Falchetti A., Tonelli F., Castello R., Furlani R., Scappaticci S., Fraccaro M. Larsson C. Homozygotes for the autosomal dominant neoplasia syndrome (MEN I). Am. J. Hum. Genet. 53: 1167, 1993.

    PubMed Central  PubMed  CAS  Google Scholar 

  22. Kidd K.K., Bowcock A.M., Schmidtke J., Track R.K., Ricciuti F., Hutching G., Bale A., Pearson P. Willard H.F., with help from Gelernter J., Giuffra R., and Kubzdela K. Human gene mapping 10. Cytogenet. Cell. Genet. 51: 622, 1989.

    Article  PubMed  CAS  Google Scholar 

  23. Tokino T., Takahashi E., Mori M., Tanigami A., Glaser T., Park J.W., Jones C., Hori T., Nakamura Y. Isolation and mapping of 62 new RFLP markers on human chromosome 11. Am. J. Hum. Genet. 48: 258,1991.

    PubMed Central  PubMed  CAS  Google Scholar 

  24. Tanigami A., Tokino T., Takiguchi S., Mori M., Glaser T., Park J.W., Jones C., Nakamura Y. Mapping of 262 DNA Markers into 24 intervals on human chromosome 11. Am. J. Hum. Genet. 50: 56,1992.

    PubMed Central  PubMed  CAS  Google Scholar 

  25. Larsson C., Weber G., Kvanta E., Lewis K., Janson M., Jones C., Glaser T., Evans G., Nordenskjold M. Isolation and mapping of polymorphic cosmid clones used for sublocalization of the multiple endocrine neoplasia type 1 (MEN 1) locus. Hum. Genet. 89: 187, 1992.

    Article  PubMed  CAS  Google Scholar 

  26. Williamson R., Bowcock A., Kidd K., Pearson P., Schmidtke J., Chan H.S., Chipperfield M., Cooper D.N., Hewitt J., Lewitter F., Maidak B., Quitt M., Ricciuti F., Track R. Human gene mapping 10.5. Cytogenet. Cell Genet. 55: 457, 1990.

    Article  PubMed  CAS  Google Scholar 

  27. Nakamura Y., Larsson C., Julier C., Bystrom C., Skogseid B., Wells S., Ober K., Carlon M., Taggart T., O’ Connel P., Leppert M., Lalouel J.M., Nordenskjold M., White R. Localization of the genetic defect in multiple endocrine neoplasia type 1 within a small region of chromosome 11. Am. J. Hum. Genet. 44: 751, 1989.

    PubMed Central  PubMed  CAS  Google Scholar 

  28. Julier C., Nakamura Y., Lathrop M., O’ Connel P., Leppert M., Litt M., Mohandas T., Lalouel J.M., White R. Detailed map of the long arm of chromosome 11. Genomics 7: 335,1990.

    Article  PubMed  CAS  Google Scholar 

  29. Janson M., Larsson C., Werelius B., Jones C., Glaser T., Nakamura Y., Jones C.P., Nordenskjold M. Detailed physical map of human chromosomal region 11q12–13 shows high meiotic recombination rate around the MEN 2 locus. Proc. Natl. Acad. Sci. USA 88: 10609, 1991.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  30. Larsson C., Shepherd J., Nakamura Y., Blomberg C., Weber G., Werelius B., Hayward N., Teh B., Tokino T., Seizinger B., Skogseid B., Oberg K., Nordenskjold M. Predictive testing for multiple endocrine neoplasia type 1 using DNA polymorphism. J. Clin. Invest. 89: 1344, 1992.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  31. Larsson C., Skogseid B., Oberg K., Nakamura Y., Nordenskjold M. Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature 332: 85, 1988.

    Article  PubMed  CAS  Google Scholar 

  32. Friedman E., Sakaguchi K., Bale A.E., Falchetti A., Streeten E., Zimering M., Weinstein L, McBride W., Nakamura Y., Brandi M.L., Norton J.A., Aurbach G.D., Spiegel A., Marx S.J. Clonality of parathyroid tumors in familial multiple endocrine neoplasia type 1. N. Engl. J. Med. 321: 213, 1989.

    Article  PubMed  CAS  Google Scholar 

  33. Falchetti A., Bale A.E., Amorosi A., Bandini S., Cicchi P., Bordi C., Marx S.J., Brandi M.L. Progression of uremic hyperparathyroidism involves allelic loss in the men 1 region on chromosome 11. J. Clin. Endocrinol. Metab. 76: 139,1993.

    PubMed  CAS  Google Scholar 

  34. Thakker R.V., Bouloux P., Wooding C., Chotai K., Broad P.M., Spurr N.K., Besser G.M., O’ Riordan J.L Association of parathyroid tumors in multiple endocrine neoplasia type I with loss of alleles on chromosome 11. N.Engl.J.Med. 321: 218, 1989.

    Article  PubMed  CAS  Google Scholar 

  35. Knudson A.G. Mutation and cancer: statistical study of retinoblastoma. Proc. Natl. Acad. Sci. USA 68: 820,1971.

    Article  PubMed Central  PubMed  Google Scholar 

  36. Moffatt M.F. Dinucleotide repeat polymarlphism at the D11S480 locus. Hum. Mol. Genet. 2: 492,1993.

    Article  PubMed  CAS  Google Scholar 

  37. Iwasaki H., Stewart P.W., Dilley W.G., Holt M.S., Steinbrueck T.D., Wells S.A.Jr., Donis-Keller H. A minisatellite and a microsatellite polymorphism within 1.5 kb at the Human Muscle Glycogen phospholylase (PYGM) locus can be amplified by PCR and have combined informativeness of PIC 0.95. Genomics 13: 7, 1992.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Morelli, A., Falchetti, A., Castello, R. et al. Genetic screening to identify the gene carrier in Italian and German kindreds affected by multiple endocrine neoplasia type 1 (MEN 1) syndrome. J Endocrinol Invest 18, 329–335 (1995). https://doi.org/10.1007/BF03347833

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03347833

Key-words

Navigation